During the past decade, Ohio Sleep Medicine Institute conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 9 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 7 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ohio Sleep Medicine Institute" #1 sponsor was "Jazz Pharmaceuticals" with 6 trials, followed by "Harmony Biosciences, LLC" with 4 trials sponsored, "Noctrix Health, Inc." with 3 trials sponsored, "Vanda Pharmaceuticals" with 3 trials sponsored and "Avadel" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio Sleep Medicine Institute" #1 collaborator was "Aspen Clinical Research" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "Nyxoah, Inc." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ohio Sleep Medicine Institute" are "Narcolepsy" (9 trials), "Obstructive Sleep Apnea" (7 trials), "Excessive Daytime Sleepiness" (4 trials), "Restless Legs Syndrome" (4 trials) and "Idiopathic Hypersomnia" (3 trials). Many other conditions were trialed in "Ohio Sleep Medicine Institute" in a lesser frequency.

Most popular intervention types in "Ohio Sleep Medicine Institute" are "Drug" (21 trials), "Device" (10 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Placebo oral tablet" (4 trials), "JZP-110" (3 trials), "tasimelteon" (3 trials) and "FT218" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ohio Sleep Medicine Institute" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Ohio Sleep Medicine Institute". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Ohio Sleep Medicine Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio Sleep Medicine Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".